← Back
NeuroTrials.ai
Neurology Clinical Trial Database

OPTIMIST

Optimal Post Tpa-Iv Monitoring in Ischemic STroke

Year of Publication: 2020

Authors: Roland Faigle, Jaime Butler, Juan R. Carhuapoma, ..., Victor C. Urrutia

Journal: The Neurohospitalist

Citation: Neurohospitalist 2020;10(1):11-15

Link: https://doi.org/10.1177/1941874419845229

PDF: https://pmc.ncbi.nlm.nih.gov/articles/PMC6900650/


Clinical Question

Can post-IVT stroke patients with low NIHSS (<10) and no critical care needs at the end of the IVT infusion be safely monitored using a low-intensity monitoring protocol?

Bottom Line

Low-intensity post-IVT monitoring is feasible and safe in carefully selected low-risk stroke patients (NIHSS <10, no critical care needs). None of the 35 patients required ICU transfer or critical care intervention within 24 hours, and outcomes were excellent with 82.9% discharged home.

Major Points

  • Pragmatic single-arm safety study of 35 post-IVT patients at a comprehensive stroke center
  • Low-intensity protocol: q15min monitoring for first 2 hours, then q1h for 1 hour, q2h for 8 hours, then q4h until 24 hours post-IVT
  • 0% of patients required ICU transfer or critical care intervention in first 24 hours (primary outcome)
  • Patients transferred to stroke unit (telemetry with 1:3 nurse ratio) without ICU capabilities
  • Median NIHSS improved from 3 at baseline to 1 at 24 hours and 0 at 90 days
  • 82.9% discharged home; no in-hospital deaths
  • 4 patients (11.4%) were stroke mimics
  • Two patients required ICU later: one for post-CEA care, one on day 4 for hemorrhagic transformation on heparin

Design

Study Type: Pragmatic, prospective, single-center, open-label, single-arm safety study

Randomization:

Blinding: Open-label (no blinding)

Enrollment Period: March 1, 2014 to March 31, 2018

Follow-up Duration: 90 days

Centers: 1

Countries: USA

Sample Size: 35

Analysis: Descriptive statistics; frequencies for categorical variables; medians with IQR for continuous variables; Stata version 15


Inclusion Criteria

  • Age 18-80 years
  • NIHSS <10 at time of presentation
  • NIHSS <10 at end of IVT infusion
  • No critical care needs by end of IVT infusion
  • Received IVT for acute stroke

Exclusion Criteria

  • Underwent endovascular therapy
  • Critical care needs by end of IVT infusion
  • NIHSS ≥10

Baseline Characteristics

CharacteristicControlActive
NoteSingle-arm study - no control group
N35
Age - Median (range)54 years (32-79)
Male60.0%
Black race62.9%
Pre-IVT NIHSS - Median (IQR)3 (1-6)
Pre-IVT mRS - Median (range)0 (0-4)
IVT window <3 hours65.7%
BP systolic - Median (IQR)157 mm Hg (140-177)
BP diastolic - Median (IQR)86 mm Hg (75-100)
Glucose - Median (IQR)119 mg/dL (94-138)
Hypertension80.0%
Hyperlipidemia42.9%
Diabetes mellitus20.0%
Atrial fibrillation14.3%
Smoking28.6%
Antiplatelet use40.0%
Anticoagulation use2.9%
Statin use37.1%
Mean infarct volume3.4 mL (range 0-44.8)

Arms

FieldLow-intensity monitoring protocol
InterventionVital signs and neurological assessments: q15min during IVT and first hour post-IVT (standard care), then on stroke unit admission, q1h for 1 hour, q2h for 8 hours, then q4h until 24 hours post-IVT. Stroke unit had 1:3 nurse ratio without critical/intermediate care capabilities.
Duration24 hours post-IVT, then 90-day follow-up

Outcomes

OutcomeTypeControlInterventionHR / OR / RRP-value
Need for critical care intervention in first 24 hours after IVT, or perceived need to transfer patient to ICU even if no actual critical care intervention was performedPrimary0/35 (0%)
NIHSS at 24 hours - Median (IQR)Secondary1 (0-3)
NIHSS improvement at 24 hours from baseline - Median (IQR)Secondary2 (0-4)
NIHSS at discharge - Median (IQR)Secondary1 (0-2)
mRS at discharge - Median (range)Secondary1 (0-3)
NIHSS at 90 days - Median (IQR), n=28Secondary0 (0-1)
mRS at 90 days - Median (range), n=33Secondary0 (0-6)
Discharge to homeSecondary29/35 (82.9%)
Length of stay - Median (IQR)Secondary2 days (2-3)
Symptomatic hemorrhagic transformationAdverse0 (0%)
Asymptomatic hemorrhagic transformationAdverse4 (11.4%)
In-hospital deathAdverse0 (0%)
Delayed ICU admission (after 24 hours)Adverse2 (5.7%) - 1 for post-CEA care, 1 on day 4 for hemorrhagic transformation on heparin

Subgroup Analysis

Stroke mimics comprised 11.4% of the cohort (3 conversion disorder, 1 seizure). No intracranial large vessel occlusions; one patient had extracranial ICA occlusion from dissection, another had symptomatic high-grade ICA stenosis.


Criticisms

  • Small sample size (n=35) limits generalizability and statistical power
  • Single-arm design without randomized comparison to standard monitoring
  • Single-center study at a comprehensive stroke center may not generalize to other settings
  • Not powered to show functional outcomes are comparable to standard-of-care monitoring
  • Excluded patients who underwent mechanical thrombectomy
  • Median time from end of IVT to transfer out of ED was 109 minutes (longer than intended 1 hour)
  • Results not generalizable to post-thrombectomy patients or those with higher NIHSS
  • Selection criteria may enrich for stroke mimics and very mild strokes

Funding

Dr Faigle supported by institutional KL2 grant from Johns Hopkins Institute for Clinical and Translational Research (ICTR), funded by Grant Number KL2TR001077 from National Center for Advancing Translational Sciences (NCATS), NIH

Based on: OPTIMIST (The Neurohospitalist, 2020)

Authors: Roland Faigle, Jaime Butler, Juan R. Carhuapoma, ..., Victor C. Urrutia

Citation: Neurohospitalist 2020;10(1):11-15

Content summarized and formatted by NeuroTrials.ai.